Global Needle Free Injection Systems Market showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx billion over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 17.01% during the forecast period that is 2017-2025.   

Global Market Growth Opportunities (Revenue, Growth) By 2017-2025

Market Analysis

Needle-free injection system is an advanced way of injecting drugs into the patient compared to the conventional needle injection system, as needle free injections don’t penetrate into the human skin. The needle free injections market is expected to grow due to increase in incidences of chronic diseases and communicable disease which are caused due to injection of needles. Thus, the needle free injection system reduces skin bruising, bleeding, and other diseases.

Moreover, human skin is extremely immunogenic, needle free injections helps to improve immune responsiveness towards vaccines. For instance, needle free injection systems can be used for the immunizing process of influenza, typhoid, diphtheria, tetanus, pertussis hepatitis, and other mass immunizations (measles, smallpox). These factors are expected to boost the needle free injection system market. Organizations such as World Health Organization (WHO), Centre for Disease Control (CDC), and others are highly involved in the development of needle free injections for drug, which is expected to fuel the needle free injection systems market. The market of needle free injection is also anticipated to grow due to increase in usage of self- administered drugs. Thus, the rising inclination of the populous towards self-administered drugs coupled with its safety, protection towards skin bleeding and others factors, owing to which the needle free injection systems market is expected to propel during the forecast period.

Needle Free Injection Systems & its Importance:

The needle free injection system market is constantly increasing due to various factors such as growing needle injuries associated with injections, needle phobia among adults and children, and other. According to the study in Behavioral Neurology, in 2014, about 5-6% of the global population is expected to suffer from needle phobia which in turn impacts the patient’s clinic or hospital visits, due to avoidance of treatments by needle.

Needle phobia has a huge impact on the vaccination process of infants and children. According to the study printed by Clinical Journal of Pain, in 2015, 12 billion vaccinations per year globally were recorded, where needle syringe system were used, the advantage of needle free injection is expected to thus boost the market. The growing demand for vaccines and other products is expected to be a major factor for the growth of needle free injection system market during the forecast period. In 2018, according to World Health Organization (WHO), 86% of the infants, globally, were vaccinated for over 30 diseases, although, 20 million children remained unvaccinated. Thus, the demand for vaccines is expected to boost the growth of needle free injection systems market during the forecast period. Growing research on biologics is expected to propel the growth for the market. Biologicals are prescribed and launched for the treatment of diseases such as ulcerative colitis, Crohn’s disease, multiple sclerosis, Alzheimer’s disease, cancer, and others. Owing to these factors the needle free injection system market is expected to propel during the forecast period.

Regional Analysis

The global needle free injection system market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. The needle free injection systems market is expected to be dominated by North America due to high occurrence of chronic diseases such as cancer and diabetes. According to the American Cancer Society, in 2017, cancer was accounted as the second leading cause for death followed by cardiovascular diseases in the U.S. However, about 1.7 million cancer cases were accounted for the year 2016 in U.S. The increasing number of approvals for biologic drug in U.S. is expected to drive the growth for needle free injection system market during the forecast period. For instance, according to the Food and Drug Administration (FDA), in 2017, over 20 biologic formulation approvals were received from the FDA. Owing to these factors the needle free injection systems market is expected to propel during the forecast period.

Global Needle Free Injection Systems Market Study Objective

1. To forecast the market size of needle free injection systems market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of needle free injection systems market on the basis of region, substrate and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate significant factors that will have major impact on the growth of needle free injection systems market, such as drivers, restraints, challenges and opportunities.

4. Regional analysis of needle free injection systems market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa and Asia Pacific.

5. Strategic analysis of micromarkets, in terms of individual prospects, opportunities, growth trends and their involvement in overall market.

6. To provide detailed analysis of competitive and strategic developments in the needle free injection systems market like new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

The global players are more focused on strategies to withstand their place in the competitive market with collaborations, mergers, partnership, acquisition, and innovations. For instance, in 2017, Portal Instruments and Takeda Pharmaceutical collaborated towards the development of the needle-free drug delivery device for Crohn's diseases, hepatitis, and others. Major players for the needle free injection systems market includes Endo International plc, Antares Pharma, Inc., Zogenix, PharmaJet, Portal Instruments, Inc., Medical International Technology, Inc., Bioject Medical Technologies Inc., INJEX Pharma AG, PenJet Corporation, and Valeritas, Inc. among others.

Global Needle Free Injection Systems Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.